8-K
Current Report
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001193125-22-196671
Exit or restructuring costs · Regulation FD disclosure
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d382508d8k.htm…